Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albiglutide vs Placebo with Intensified Insulin in T2DM
NCT02229240Phase 3Withdrawn
- Sponsor
- GSK
- Start
- Aug 2015
- Primary completion
- Dec 2015
- Modality
- Fc-Fusion Proteins
01
Overview
A Phase 3 trial of albiglutide in type 2 diabetes mellitus (T2DM), sponsored by GSK. Planned start Aug 2015; status: withdrawn.
02
Drugs
albiglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02229240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02229240.